WANBURY
Smallcap | BSE
Sector
Index
Here's the live share price of Wanbury along with daily highs, lows, percentage changes and volume trends, and, all financial information.
1.97₹ 5.00
As on May 11, 2026, 02:54 PM IST
Wanbury Price Performance
Today's LowToday's High
₹248.55₹261.50
₹259.00
52 Weeks' Low52 Weeks' High
₹162.00₹330.00
₹259.00
Open Price
₹248.55
Prev. Close
₹254.00
Volume
6,109
Wanbury Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Wanbury | 0.04 | 12.66 | 0.37 | 6.13 | 7.37 | 75.82 | 20.56 |
| Sun Pharmaceutical Industries | 3.64 | 9.12 | 9.94 | 10.40 | 7.40 | 25.07 | 21.83 |
| Divi's Laboratories | 3.70 | 13.23 | 10.29 | 0.80 | 12.41 | 25.85 | 10.26 |
| Torrent Pharmaceuticals | 8.31 | 10.92 | 13.62 | 18.93 | 44.70 | 40.10 | 26.81 |
| Dr. Reddy's Laboratories | -2.11 | 6.82 | 1.58 | 8.06 | 11.99 | 9.51 | 3.97 |
| Cipla | 0.92 | 7.98 | -1.53 | -12.67 | -10.59 | 12.07 | 7.98 |
| Lupin | -1.39 | -1.07 | 3.30 | 14.30 | 11.47 | 44.86 | 13.14 |
| Mankind Pharma | 9.26 | 19.49 | 17.85 | 9.76 | 1.71 | 19.90 | 11.50 |
| Zydus Lifesciences | 6.32 | 5.08 | 2.70 | 0.10 | 7.98 | 21.74 | 8.70 |
| Aurobindo Pharma | 7.36 | 11.37 | 24.19 | 29.38 | 28.20 | 34.40 | 7.31 |
| Laurus Labs | 15.67 | 17.33 | 28.92 | 26.95 | 115.88 | 56.04 | 20.95 |
| Alkem Laboratories | 4.37 | 5.05 | -1.85 | -0.69 | 13.95 | 15.97 | 13.23 |
| Glenmark Pharmaceuticals | -2.69 | 7.92 | 18.51 | 27.72 | 67.77 | 61.03 | 30.16 |
| Biocon | 9.41 | 13.78 | 5.22 | 2.92 | 19.21 | 16.87 | 0.46 |
| Abbott India | 8.68 | 7.13 | 0.58 | -6.30 | -8.32 | 7.96 | 11.35 |
| Anthem Biosciences | 2.93 | 8.54 | 16.17 | 10.91 | 7.07 | 2.36 | 1.41 |
| GlaxoSmithKline Pharmaceuticals | 4.59 | 3.50 | -2.72 | -3.84 | -11.44 | 24.17 | 10.95 |
| Ipca Laboratories | -0.20 | 5.40 | 5.26 | 13.55 | 12.71 | 29.73 | 7.94 |
| Ajanta Pharma | 9.04 | 12.00 | 7.74 | 21.85 | 21.25 | 34.13 | 18.12 |
| J B Chemicals & Pharmaceuticals | 7.97 | 12.22 | 17.37 | 21.94 | 44.78 | 28.73 | 25.44 |
Over the last one year, Wanbury has gained 7.37% compared to peers like Sun Pharmaceutical Industries (7.40%), Divi's Laboratories (12.41%), Torrent Pharmaceuticals (44.70%). From a 5 year perspective, Wanbury has outperformed peers relative to Sun Pharmaceutical Industries (21.83%) and Divi's Laboratories (10.26%).
Wanbury Financials
Wanbury Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 254.55 | 254.5 |
| 10 | 257.14 | 255.29 |
| 20 | 255 | 253.86 |
| 50 | 250.31 | 249.19 |
| 100 | 239.33 | 246.18 |
| 200 | 247.38 | 245.44 |
Wanbury Share Holding Pattern
In the latest quarter, Wanbury saw a drop in promoter holding to 43.01%, while DII stake unchanged at 0.00%, FII holding fell to 0.59%, and public shareholding moved up to 56.39% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Wanbury Corporate Actions
Date Time | Announcement |
|---|---|
| May 06, 2026, 12:02 AM IST IST | Wanbury - Board Meeting Intimation for Notice Of Board Meeting For Approving The Audited Financial Results & Statements Of Th |
| Apr 28, 2026, 11:25 PM IST IST | Wanbury - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Apr 08, 2026, 10:37 PM IST IST | Wanbury - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A |
| Apr 06, 2026, 11:45 PM IST IST | Wanbury - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Mar 24, 2026, 06:08 AM IST IST | Wanbury - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
About Wanbury
Wanbury Ltd. is a Public Limited Listed company incorporated on 11/08/1988 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L51900MH1988PLC048455 and registration number is 048455. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 599.51 Cr. and Equity Capital is Rs. 32.77 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressBSEL Tech Park, B-Wing, 10th Floor, Sector 30-A, New Mumbai Maharashtra 400703
- Contact
Management
- Mr. K ChandranWhole Time Director
- Mr. Mohan Kumar RayanaWhole Time Director
- Ms. Anupama VaidyaInd. Non-Executive Woman Director
- Mr. Mridul Sumanlal MehtaInd. Non-Executive Director
- Mr. P V Sankar DassInd. Non-Executive Director
- Mr. Manojkumar K GursahaniInd. Non-Executive Director
FAQs on Wanbury Share Price
What is the share price of Wanbury?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Wanbury is ₹259.00 as on May 11, 2026.
What kind of stock is Wanbury?
The Wanbury is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Wanbury?
The market cap of Wanbury is ₹901.44 Cr as on May 11, 2026.
What are today's High and Low prices of Wanbury?
Today’s highest and lowest price of Wanbury are ₹261.50 and ₹248.55.
What are the 52 Week High and 52 Week Low of Wanbury?
The 52-week high/low is the highest and lowest price at which Wanbury stock has traded in the past 52-week or nearly a year. The 52-week high of Wanbury is ₹330.00 and 52-week low of Wanbury is ₹162.00 as on May 11, 2026.
How has the Wanbury performed historically in terms of returns?
The Wanbury has shown returns of 1.97% over the past day, 13.1% for the past month, 0.76% over 3 months, 7.78% over 1 year, 76.05% across 3 years, and 20.65% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Wanbury?
P/E ratio of and PB ratio of Wanbury are 20.97 and 22.03 on May 11, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse